These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4399497)

  • 1. Recovery of the amine uptake-storage mechanism in nerve granules after reserpine treatment: inhibition by axotomy.
    Andén NE; Lundborg P
    J Pharm Pharmacol; 1970 Mar; 22(3):233-5. PubMed ID: 4399497
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of axoplasmic transport of amine granules for the functions of adrenergic neurons.
    Häggendal J; Dahlström A
    Acta Neuropathol; 1971; 5():Suppl 5:238-48. PubMed ID: 4104926
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversal of the reserpine-induced suppression of the conditioned avoidance response by L-dopa: correlation of behavioral and biochemical differences in two strains of mice.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Feb; 159(2):422-8. PubMed ID: 5638661
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice.
    Boggan WO; Seiden LS
    Physiol Behav; 1971 Mar; 6(3):215-7. PubMed ID: 5125476
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavior and biochemical effects of preferentially protecting monoamines in the brain against the action of reserpine.
    Butcher LL; Rhodes DL; Yuwiler A
    Eur J Pharmacol; 1972 May; 18(2):204-12. PubMed ID: 4537669
    [No Abstract]   [Full Text] [Related]  

  • 6. Storage and synthesis of norepinephrine in the reserpine-treated rat brain.
    Glowinski J; Iversen LL; Axelrod J
    J Pharmacol Exp Ther; 1966 Mar; 151(3):385-99. PubMed ID: 4380046
    [No Abstract]   [Full Text] [Related]  

  • 7. Catecholamines in fetal and newborn rat brain.
    Coyle JT; Henry D
    J Neurochem; 1973 Jul; 21(1):61-7. PubMed ID: 4146461
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of catecholamine precursors and monoamine oxidase inhibition on the amine levels of central catecholamine neurons after reserpine treatment or tyrosine hydroxylase inhibition.
    Corrodi H; Fuxe K
    Life Sci; 1967 Jul; 6(13):1345-50. PubMed ID: 6035763
    [No Abstract]   [Full Text] [Related]  

  • 9. Brain catecholamines and the reserpine-induced stimulation of the pituitary-adrenal system.
    Hirsch GH; Moore KE
    Neuroendocrinology; 1968; 3(6):398-405. PubMed ID: 4388076
    [No Abstract]   [Full Text] [Related]  

  • 10. Behavioural and biochemical effects of L-dopa after inhibition of dopamine- -hydroxylase in reserpine pretreated rats.
    Ahlenius S; Engel J
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 270(4):349-60. PubMed ID: 4255378
    [No Abstract]   [Full Text] [Related]  

  • 11. L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition.
    Butcher L; Engel J; Fuxe K
    J Pharm Pharmacol; 1970 Apr; 22(4):313-6. PubMed ID: 4392579
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of manipulation of biogenic amine levels upon spinal cord reflexes.
    Wooley DF
    Proc West Pharmacol Soc; 1968; 11():65-7. PubMed ID: 4390202
    [No Abstract]   [Full Text] [Related]  

  • 13. Dopa-induced locomotor stimulation after inhibition of extracerebral decarboxylase.
    Bartholini G; Blum JE; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):297-301. PubMed ID: 4390121
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of reserpine and a tyrosine hydroxylase inhibitor on the monoamine levels in different regions of the rat central nervous system.
    Andén NE
    Eur J Pharmacol; 1967 Jan; 1(1):1-5. PubMed ID: 6058896
    [No Abstract]   [Full Text] [Related]  

  • 15. Mode of action of L-DOPA on central noradrenaline mechanisms.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):1-10. PubMed ID: 4260802
    [No Abstract]   [Full Text] [Related]  

  • 16. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 17. The uptake and storage of H3-norepinephrine in the reserpine-pretreated rat heart.
    Iversen LL; Glowinski J; Axelrod J
    J Pharmacol Exp Ther; 1965 Nov; 150(2):173-83. PubMed ID: 4379176
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of reserpine, alpha-methyltyrosine, and L-3,4-dihydroxyphenylalanine on brain tyrosine transaminase.
    Gibb JW; Webb JG
    Proc Natl Acad Sci U S A; 1969 Jun; 63(2):364-9. PubMed ID: 4389816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of disulfiram on the repletion of brain catecholamine stores.
    Goldstein M; Nakajima K
    Life Sci; 1966 Jun; 5(12):1133-8. PubMed ID: 5963538
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of reserpine on sleep and brain biogenic amine levels in the cat.
    Stern WC; Morgane PJ
    Psychopharmacologia; 1973; 28(3):275-86. PubMed ID: 4347933
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.